544312 — Hamps Bio Cashflow Statement
0.000.00%
- IN₹187.31m
- IN₹216.98m
- IN₹66.69m
Annual cashflow statement for Hamps Bio, fiscal year end - March 31st, millions except per share.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS | |
Standards: | — | IAS | IAS | IAS | — |
Status: | fx Preliminary | Final | Final | Final | Final |
Net Income/Starting Line | — | 1.22 | 3.59 | 5.01 | 2.98 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | — | 1.87 | 1.73 | 2.48 | 2.01 |
Other Non-Cash Items | |||||
Changes in Working Capital | — | -2.84 | 3.61 | -14.3 | -15.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | — | 3.33 | 12.3 | -2.92 | -7.05 |
Capital Expenditures | — | -2.91 | -8.29 | -3.62 | -37.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 7.99 | 0.799 | -0.049 | -24.8 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | 5.08 | -7.49 | -3.67 | -62 |
Financing Cash Flow Items | — | -1.9 | -1.77 | -1.5 | -1.4 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | — | -9.44 | -4.83 | 6.68 | 69.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | — | -1.03 | -0.024 | 0.095 | 0.373 |